1 Hay N, "Upstream and downstream of mTOR" 18 : 1926-1945, 2004
2 Lieberthal W, "The role of the mammalian target of rapamycin(mTOR) in renal disease" 20 : 2493-2502, 2009
3 Bae EH, "Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats" 33 : 255-262, 2010
4 Chen JK, "Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy" 16 : 1384-1391, 2005
5 Bae EH, "Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats" 25 : 1051-1059, 2010
6 Sataranatarajan K, "Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin" 171 : 1733-1742, 2007
7 Wu MJ, "Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis" 69 : 2029-2036, 2006
8 Liu Y., "Rapamycin and chronic kidney disease: beyond the inhibition of inflammation" 69 : 1925-1927, 2006
9 Park JW, "Paricalcitol attenuates cyclosporine-induced kidney injury in rats" 77 : 1076-1085, 2010
10 Iwazu Y, "Matrix metalloproteinase 2 induces epithelial-mesenchymal transition in proximal tubules from the luminal side and progresses fibrosis in mineralocorticoid/salt-induced hypertensive rats" 29 : 2440-2453, 2011
1 Hay N, "Upstream and downstream of mTOR" 18 : 1926-1945, 2004
2 Lieberthal W, "The role of the mammalian target of rapamycin(mTOR) in renal disease" 20 : 2493-2502, 2009
3 Bae EH, "Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats" 33 : 255-262, 2010
4 Chen JK, "Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy" 16 : 1384-1391, 2005
5 Bae EH, "Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats" 25 : 1051-1059, 2010
6 Sataranatarajan K, "Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin" 171 : 1733-1742, 2007
7 Wu MJ, "Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis" 69 : 2029-2036, 2006
8 Liu Y., "Rapamycin and chronic kidney disease: beyond the inhibition of inflammation" 69 : 1925-1927, 2006
9 Park JW, "Paricalcitol attenuates cyclosporine-induced kidney injury in rats" 77 : 1076-1085, 2010
10 Iwazu Y, "Matrix metalloproteinase 2 induces epithelial-mesenchymal transition in proximal tubules from the luminal side and progresses fibrosis in mineralocorticoid/salt-induced hypertensive rats" 29 : 2440-2453, 2011
11 Lloberas N, "Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats" 17 : 1395-1404, 2006
12 Diekmann F, "Mammalian target of rapamycin inhibition halts the progression of proteinuria in a rat model of reduced renal mass" 18 : 2653-2660, 2007
13 Gavras H, "Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes" 36 : 300-309, 1975
14 Iglarz M, "Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system" 17 : 597-603, 2004
15 Hostetter TH, "Hyperfiltration and glomerulosclerosis" 23 : 194-199, 2003
16 Mariappan MM, "High glucose, high insulin, and their combination rapidly induce laminin-beta1 synthesis by regulation of mRNA translation in renal epithelial cells" 56 : 476-485, 2007
17 Katso R, "Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer" 17 : 615-675, 2001
18 Lijnen PJ, "Association between transforming growth factor-beta and hypertension" 16 : 604-611, 2003
19 Miyajima A, "Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction" 58 : 2301-2313, 2000
20 Bae EH, "Altered regulation of renal sodium transporters and natriuretic peptide system in DOCA-salt hypertensive rats" 157 : 76-83, 2009
21 Huang S, "Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation" 296 : 1323-1333, 2009
22 Sun Y, "Aldosterone-induced inflammation in the rat heart : role of oxidative stress" 161 : 1773-1781, 2002